Repaglinide restrains HCC development and progression by targeting FOXO3/lumican/p53 axis.

Yifei TanYongjie ZhouWei ZhangZhenru WuQing XuQiong WuJian YangTao LvLvnan YanHong LuoYujun ShiJiayin Yang

Published in: Cellular oncology (Dordrecht, Netherlands) (2024)

Our results indicate that RPG prevented the development and progression of HCC via alteration of FOXO3/lumican/p53 axis.

Keyphrases